JP2021530438A5 - - Google Patents

Info

Publication number
JP2021530438A5
JP2021530438A5 JP2020567123A JP2020567123A JP2021530438A5 JP 2021530438 A5 JP2021530438 A5 JP 2021530438A5 JP 2020567123 A JP2020567123 A JP 2020567123A JP 2020567123 A JP2020567123 A JP 2020567123A JP 2021530438 A5 JP2021530438 A5 JP 2021530438A5
Authority
JP
Japan
Prior art keywords
antibody
pharmaceutical composition
composition according
seq
psoriasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020567123A
Other languages
English (en)
Japanese (ja)
Other versions
JP7357646B2 (ja
JP2021530438A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/034423 external-priority patent/WO2019232070A1/en
Publication of JP2021530438A publication Critical patent/JP2021530438A/ja
Publication of JP2021530438A5 publication Critical patent/JP2021530438A5/ja
Application granted granted Critical
Publication of JP7357646B2 publication Critical patent/JP7357646B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020567123A 2018-05-29 2019-05-29 乾癬の治療のための組成物及び方法 Active JP7357646B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862677590P 2018-05-29 2018-05-29
US62/677,590 2018-05-29
PCT/US2019/034423 WO2019232070A1 (en) 2018-05-29 2019-05-29 Compositions and methods for treatment of psoriasis

Publications (3)

Publication Number Publication Date
JP2021530438A JP2021530438A (ja) 2021-11-11
JP2021530438A5 true JP2021530438A5 (enExample) 2022-06-06
JP7357646B2 JP7357646B2 (ja) 2023-10-06

Family

ID=68697289

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020567123A Active JP7357646B2 (ja) 2018-05-29 2019-05-29 乾癬の治療のための組成物及び方法

Country Status (9)

Country Link
US (2) US12016921B2 (enExample)
EP (1) EP3801590A4 (enExample)
JP (1) JP7357646B2 (enExample)
KR (1) KR102940600B1 (enExample)
CN (1) CN112689512B (enExample)
AU (1) AU2019279883B2 (enExample)
CA (1) CA3101767A1 (enExample)
IL (1) IL278978B2 (enExample)
WO (1) WO2019232070A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10858422B2 (en) 2016-05-31 2020-12-08 Abcentra, Llc Methods for treating systemic lupus erythematosus with an anti-apolipoprotein B antibody
WO2019232081A1 (en) * 2018-05-29 2019-12-05 Abcentra, Llc Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis
CN112689512B (zh) 2018-05-29 2025-09-05 艾比中心有限责任公司 用于治疗银屑病的组合物和方法
EP4058042A4 (en) * 2019-11-12 2023-12-27 Abcentra, LLC METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER
AU2024240129A1 (en) 2023-03-17 2025-10-09 Oxitope Pharma B.V. Anti-phosphocholine antibodies and methods of use thereof
WO2025151468A1 (en) * 2024-01-08 2025-07-17 Abcentra, Llc Methods of identifying a subject for treatment with antibodies against oxidized low density lipoprotein using pericoronary fat attenuation index

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0103754L (sv) 2001-04-05 2002-10-06 Forskarpatent I Syd Ab Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
WO2008104194A1 (en) 2007-02-28 2008-09-04 Bioinvent International Ab Oxidized ldl and antibodies thereto for the treatment of atheroscleroti c plaques
US8557767B2 (en) 2007-08-28 2013-10-15 Uab Research Foundation Synthetic apolipoprotein E mimicking polypeptides and methods of use
AU2008342942A1 (en) * 2007-12-28 2009-07-09 Biolnvent International Ab Formulation
BRPI0908715A2 (pt) * 2008-03-18 2016-05-03 Abbott Lab métodos para tratamento da psoríase
EP2470210A2 (en) 2009-08-28 2012-07-04 BioInvent International AB Methods of treatment using anti-oxidized ldl antibodies
TW201233395A (en) 2010-10-06 2012-08-16 Abbott Lab Methods for treating psoriasis
WO2016024254A1 (en) 2014-08-15 2016-02-18 Fundació Hospital Universitari Vall D’Hebron-Institut De Recerca Therapy selection for psoriasis and psoriatic arthritis
WO2019232081A1 (en) 2018-05-29 2019-12-05 Abcentra, Llc Compositions and methods for treatment of rheumatoid arthritis and accelerated atherosclerosis
CN112689512B (zh) 2018-05-29 2025-09-05 艾比中心有限责任公司 用于治疗银屑病的组合物和方法

Similar Documents

Publication Publication Date Title
US20240417455A1 (en) Treatment for rheumatoid arthritis
AU2018200915B2 (en) Prevention of Adverse Effects Caused by CD3 Specific Binding Domains
JP2023515271A5 (enExample)
JP6554155B2 (ja) Ｉｌ−１７アンタゴニストを使用して汎発性膿疱性乾癬（ｇｐｐ）を処置する方法
AU2017201201B2 (en) Treatment for dermatological pathologies
RU2016136364A (ru) Способы лечения или предупреждения астмы посредством введения антагониста il-4r
JP2022126791A (ja) Ｉｌ－１７アンタゴニストを用いて初発プラーク型乾癬を治療する方法
JP2023520676A5 (enExample)
RU2019111921A (ru) Способы лечения тяжелого атопического дерматита путем введения ингибитора il-4r
JP2017511316A5 (enExample)
JP2024530954A5 (enExample)
JP2024516698A5 (enExample)
JP2024016237A5 (enExample)
JP2023545084A5 (enExample)
JP2021529766A5 (enExample)
CN109806393B (zh) 抗pd-1抗体、培美曲塞和铂类药物联合治疗非小细胞肺癌的用途
CA2865810A1 (en) Treatment of mucositis with immunoglobulin
JP2024536106A5 (enExample)
JP2024522620A5 (enExample)
TW202206457A (zh) 用於治療呼吸疾病之泛elr+ cxc趨化因子抗體
CA2884124C (en) Treatment for rheumatoid arthritis
Mittal et al. Monica S. Tandon, Ankit Sharma
JP2024511079A5 (enExample)
RU2024105814A (ru) Лечение атопического дерматита
TH2101002581A (th) วิธีการทรีตโรคตาโปนจากไทรอยด์โดยใช้แอนติบอดีชนิด anti-fcrn